Mycosis fungoides and Sezary syndrome – Simplifying the approach for dermatologists. Part 2: Evaluation, staging, prognosis and treatment

Simple item page
dc.contributor.authorSingh, GKen_US
dc.contributor.authorDas, Pen_US
dc.contributor.authorSrivastava, Sen_US
dc.contributor.authorSingh, Ken_US
dc.contributor.authorSingh, Ven_US
dc.contributor.authorBarui, Sen_US
dc.contributor.authorMulajkar, Den_US
dc.contributor.authorDubey, IP.en_US
dc.date.accessioned2025-06-18T11:42:21Z
dc.date.available2025-06-18T11:42:21Z
dc.date.issued2025-04
dc.description.abstractCutaneous T-cell lymphoma is a heterogeneous group of T-cell neoplasms, of which mycosis fungoides and Sezary syndrome are the most common. The prognosis depends on the stage of the disease. The early stage follows a protracted course with a five-year disease-specific survival of greater than 95% and is treated with skin-directed topical therapies, phototherapy, and oral drugs like methotrexate. Advanced disease has a five-year overall survival of less than 25% and requires management by systemic chemotherapeutic agents. This review article is the second part out of the two covering the staging, prognosis, and treatment from a dermatologist’s perspective.en_US
dc.identifier.affiliationsDepartment of Dermatology, Bharati Vidyapeeth’s Medical College, Pune, Indiaen_US
dc.identifier.affiliationsDepartment of Dermatology, Armed Forces Medical College, Pune, Indiaen_US
dc.identifier.affiliationsDepartment of Dermatology, Base Hospital Delhi Cantonment and Army College of Medical Sciences Delhi Cantt, Indiaen_US
dc.identifier.affiliationsDepartment of Pathology, Army Hospital, Research and Referral Kolkata, Indiaen_US
dc.identifier.affiliationsDepartment of Pathology, Armed Forces Medical College, Pune, Indiaen_US
dc.identifier.affiliationsDepartment of Pathology, Base Hospital, Delhi Cantonment and Army College of Medical Sciences, Delhi Cantt, Indiaen_US
dc.identifier.affiliationsDepartment of Medical Oncology, Army Hospital Research and Referral, Delhi, Indiaen_US
dc.identifier.affiliationsDepartment of Nuclear Imaging, Army Hospital Research and Referral, Delhi, India.en_US
dc.identifier.citationSingh GK, Das P, Srivastava S, Singh K, Singh V, Barui S, Mulajkar D, Dubey IP.. Mycosis fungoides and Sezary syndrome – Simplifying the approach for dermatologists. Part 2: Evaluation, staging, prognosis and treatment. Indian Journal of Dermatology, Venereology and Leprology. 2025 Apr; 91(2): 180-187en_US
dc.identifier.issn0378-6323
dc.identifier.issn0973-3922
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/249390
dc.languageenen_US
dc.publisherScientific Scholar on behalf of Indian Association of Dermatologists, Venereologists & Leprologists (IADVL), India.en_US
dc.relation.issuenumber2en_US
dc.relation.volume91en_US
dc.source.urihttps://dx.doi.org/10.25259/IJDVL_754_2023en_US
dc.subjectMycosis fungoidesen_US
dc.subjectSezary syndromeen_US
dc.subjectCTCLen_US
dc.subjectcutaneous T cell lymphomaen_US
dc.titleMycosis fungoides and Sezary syndrome – Simplifying the approach for dermatologists. Part 2: Evaluation, staging, prognosis and treatmenten_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ijdvl2025v91n2p180.pdf
Size:
392.46 KB
Format:
Adobe Portable Document Format
Download
Collections
Indian Journal of Dermatology, Venereology and Leprology